XML 43 R34.htm IDEA: XBRL DOCUMENT v3.25.3

Investment in MiNK Therapeutics, Inc. (Tables)

9 Months Ended

Sep. 30, 2025

Investment Company [Abstract]

Summarized Balance Sheet Information and Results of Operations

The following tables present summarized balance sheet information as of September 30,2025 and summarized results of operations for the three months since the date of deconsolidation (in thousands):

		September 30, 2025
Current assets		$	14,534
Non-current assets			429
Current liabilities			13,434
Non-current liabilities			15,043
		Three Months Ended September 30,
		2025
Net loss		$	(2,888	)
Net loss attributable to Agenus			(1,386	)

X

- References

No definition available.

+ Details

Name:	us-gaap_InvestmentCompanyAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of summarized financial information for nonconsolidated subsidiary of investment company. Excludes information consolidated by reporting entity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S50
-Paragraph 1
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 235
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1

+ Details

Name:	us-gaap_InvestmentCompanyNonconsolidatedSubsidiarySummarizedFinancialInformationTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration